Yazar "Nursen, Hayri Ahmet Burak" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Original Location of Congenital Nasal Sinus Midcolumella: A Modified Inverted V Incision Technique
    (Springer India, 2023) Ismayilzade, Majid; Tekecik, Mahmut; Soylu, Arda; Nursen, Hayri Ahmet Burak; Ince, Bilsev; Dadaci, Mehmet
    Among the rare congenital malformations, congenital nasal sinuses with blind end are extremely unusual. To the best of our knowledge, a sinus located in the midcolumellar region has not been reported yet. Since there is no consensus about the treatment of midcolumellar sinus, to manage the case as individually as possible was our priority. Considering the patient's age, aesthetic concerns, and requirement of septorhinoplasty in the future, the known inverted V incision was modified to provide surgical excision without any extra scar in the midcolumellar line. This report emphasizes a patient-specific treatment of a 15-year-old female patient presented for congenital sinus in the midcolumellar area.
  • Küçük Resim Yok
    Öğe
    Toxic Epidermal Necrolysis in a Patient with Allopurinol, Colchicine and Alcohol Use
    (Emergency Medicine Physicians Assoc Turkey, 2020) Daye, Munise; Temiz, Selami Aykut; Arslan, Sevket; Yosunkaya, Alper; Gumus, Selim; Uyanik, Orkun; Nursen, Hayri Ahmet Burak
    Introduction: Toxic epidermal necrolysis is a severe, acute, mucocutaneous, life-threatening hypersensitivity syndrome with high mortality and bullous lesions on the skin, eyes and mucous membranes. It often develops due to drugs. Sulfonamide group antibiotics and antiepileptic drugs are the most commonly responsible agents. Allopurinol is a common cause of toxic epidermal necrolysis as in most drug reactions. Colchicine is widely used in dermatology and rheumatology and is generally known as an agent with a broad safety profile. Case report: Here we present a case of toxic epidermal necrolysis in our case with allopurinol, colchicine and alcohol use in order to draw attention to the increased risk of drug coexistence. Conclusion: Again, we wanted to draw attention to the management of our case and the efficacy and safety of high-dose intravenous immunoglobulin therapy.